ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 132 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,233 | -19.6% | 15,411 | +0.3% | 0.00% | – |
| Q2 2023 | $57,469 | +16.2% | 15,366 | +4.1% | 0.00% | – |
| Q1 2023 | $49,443 | -38.5% | 14,759 | -11.7% | 0.00% | – |
| Q4 2022 | $80,361 | -8.7% | 16,707 | +8.4% | 0.00% | – |
| Q3 2022 | $88,000 | -18.5% | 15,416 | +2.4% | 0.00% | – |
| Q2 2022 | $108,000 | -28.0% | 15,055 | -27.3% | 0.00% | – |
| Q1 2022 | $150,000 | -35.1% | 20,721 | -19.8% | 0.00% | – |
| Q4 2021 | $231,000 | -20.3% | 25,825 | +212.1% | 0.00% | -100.0% |
| Q3 2021 | $290,000 | -21.6% | 8,274 | -51.9% | 0.00% | 0.0% |
| Q2 2021 | $370,000 | +45.7% | 17,203 | +319.0% | 0.00% | 0.0% |
| Q1 2021 | $254,000 | – | 4,106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
| EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
| Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
| CM Management, LLC | 100,000 | $894,000 | 0.68% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
| PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
| Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
| HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
| Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
| Parkwood LLC | 71,932 | $643,000 | 0.11% |